WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

China Approves World’s First CAR-T Therapy for Solid Tumors

CARsgen’s Kailimei wins clearance for late-line CLDN18.2-positive, HER2-negative gastric cancer, marking a milestone for cell therapy beyond blood cancers

Raccontata damorningstar.comfiercepharma.comcaixinglobal.comadnkronos.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
caixinglobal.comStai leggendo1 g fa

China Approves World’s First CAR-T Therapy for Solid Tumors

CARsgen’s Kailimei wins clearance for late-line CLDN18.2-positive, HER2-negative gastric cancer, marking a milestone for cell therapy beyond blood cancers

originale
fiercepharma.com2 g fa

CARsgen makes history as China approves world's first CAR-T therapy for solid tumors

CARsgen gets first CAR-T approval for solid tumors from China's NMPA, median PFS 3.25 vs 1.77 months (gastric cancer). Validates cell therapy for solid tumors and signals Chinese biotech maturity; reshapes global licensing partnerships and biotech investment strategy.

Leggi questa versione → originale
morningstar.com2 g fa

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

Leggi questa versione → originale
adnkronos.com17 h fa

World's First Solid Tumor CAR-T Approved: Jiahui International Cancer Center Provides Access for Patients…

SHANGHAI, June 24, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) welcomes the approval of Satri-cel (CT041, Kaileimei®), the world's first CAR-T cell therapy approved for the treatment of a solid tumor,…

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 22 giugno 2026·morningstar.com

    CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

    CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

  2. lunedì 22 giugno 2026·fiercepharma.com

    CARsgen makes history as China approves world's first CAR-T therapy for solid tumors

    The world’s first CAR-T therapy for solid tumors has passed muster in China, with the country's National Medical Products Administration (NMPA) giving the green light to CARsgen…

  3. martedì 23 giugno 2026·caixinglobal.com

    China Approves World’s First CAR-T Therapy for Solid Tumors

    CARsgen’s Kailimei wins clearance for late-line CLDN18.2-positive, HER2-negative gastric cancer, marking a milestone for cell therapy beyond blood cancers

  4. mercoledì 24 giugno 2026·adnkronos.com

    World's First Solid Tumor CAR-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide

    SHANGHAI, June 24, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) welcomes the approval of Satri-cel (CT041, Kaileimei®), the world's first CAR-T cell therapy…